STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC?

Lennard Y W Lee¹, Summaya Mohammad¹, Thomas Starkey¹, Siow-Ming Lee^{2

3}

Affiliations

¹ Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
² Department of Oncology, University College London Hospitals, London, UK.
³ Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.

Editorial

Lennard Y W Lee et al. Transl Lung Cancer Res. 2018 Dec.

. 2018 Dec;7(Suppl 4):S381-S384.

doi: 10.21037/tlcr.2018.09.14.

Lennard Y W Lee¹, Summaya Mohammad¹, Thomas Starkey¹, Siow-Ming Lee^{2

3}

¹ Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
² Department of Oncology, University College London Hospitals, London, UK.
³ Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer.
Njatcha C, Farooqui M, Kornberg A, Johnson DE, Grandis JR, Siegfried JM. Njatcha C, et al. Mol Cancer Ther. 2018 Sep;17(9):1917-1926. doi: 10.1158/1535-7163.MCT-17-1194. Epub 2018 Jun 11. Mol Cancer Ther. 2018. PMID: 29891486 Free PMC article.

1. Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511:543-50. 10.1038/nature13385 - DOI - PMC - PubMed
1. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489:519-25. 10.1038/nature11404 - DOI - PMC - PubMed
1. Sacco JJ, Clague MJ. Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance. Transl Lung Cancer Res 2015;4:242-52. - PMC - PubMed
1. Plowright L, Harrington KJ, Pandha HS, et al. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009;100:470-5. 10.1038/sj.bjc.6604857 - DOI - PMC - PubMed
1. Tong M, Wang J, Jiang N, et al. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis. PLoS One 2017;12:e0182282. 10.1371/journal.pone.0182282 - DOI - PMC - PubMed